793681.207‘Clinical Medical Management‘ is provided in Newham, Plaistow.

Our clinical medicines management draws on a wide range of clinical and non-clinical competencies and skills. Daily tasks undertaken by our pharmacists include:

  • clinical scrutiny of prescriptions;
  • oversight of safe dispensing processes;
  • providing patients with advice about medicines and treatments;
  • provision of public health information to patients and customers and promotion of wellness;
  • signposting people to other services, self-care organisations or information resources;
  • assessment and treatment for minor ailments;
  • professional oversight of the sales of over the counter (OTC) medicines;
  • liaison with other healthcare professionals;
  • clinical review services for specific patient groups, e.g. asthma, diabetes, hypertension;
  • medicines management support for GP practices, e.g. supporting practice formulary and clinical guideline implementation, repeat prescription management; and
  • providing locally commissioned Enhanced services such as supply of Prescription Only Medicines (POMs) under Patient Group Directions (PGDs), screening services, public health interventions and treatments.

We  are ideally placed to provide an active medicines management service and  have expert knowledge of medicines, we know patients  medication history, we are conveniently located and accessed without the need for an appointment.

  • Medicines management consists of two major components.
  • First, regular and frequent structured discussion with the patient, comprising counselling in relation to the following:
  • compliance and commitment to therapy;
  • side effects and toxicity;
  • ineffective treatments;
  • adverse reactions;
  • suitability of dosage form;
  • perceived acceptability of medication;
  • food interactions;
  • lifestyle;
  • general feeling of well-being;
  • family support systems;
  • GP referral system.

Secondly, a structured assessment of the patient’s prescribed medicine(s), to inform discussion and review with the patient’s GP, including the following:

  • monitoring for drug interaction;
  • consideration of replacement of patent expired brands with generics;
  • reduced side effects;
  • therapeutic interchange;
  • reduction of polymedicine;
  • more economic prescribed quantities;
  • more effective drug regimens;
  • evidence based practice.